Sharma, Vishnu, Vansh Bagrodia, and Aayush Kulshreshtra. “Enhancing Hemophilia A Management: Emicizumab As a Cost-Effective Adjunct to Standard Therapy for Inhibitor Patients”. International Journal of Basic & Clinical Pharmacology 13, no. 3 (April 25, 2024): 395–397. Accessed October 23, 2025. https://www.ijbcp.com/index.php/ijbcp/article/view/5579.